Top Markets
Coin of the day
Genovate Biotechnology Co., Ltd. Genovate Biotechnology Co., Ltd.

Genovate Biotechnology Co., Ltd.

4130
Pozycja w akcjach #21465
Genovate Biotechnology Co., Ltd. is a Taiwanese enterprise dedicated to the... Genovate Biotechnology Co., Ltd. is a Taiwanese enterprise dedicated to the research, development, production, and commercialization of various products. These offerings primarily aim to prevent and treat illnesses resulting from viral and bacterial infections. The company's diverse portfolio extends to drugs, active pharmaceutical ingredients (APIs), intermediates, and specialized release agents, which are crucial for addressing a range of health issues including cardiovascular, esophageal, gastrointestinal, cancer, and autoimmune conditions. Complementing its pharmaceutical offerings, Genovate also manufactures controlled-release Western medicine formulations and cosmetic items. Established in 1982, the company's operations are headquartered in Hsinchu City, Taiwan.
Cena akcji
$0.84903405
Ostatnia synchronizacja: 2026-07-27
Kapitalizacja rynkowa
$106.63M
Zmiana (1 dzień)
0.00%
Zmiana (1 rok)
38.69%
Kraj
TW
Handel Genovate Biotechnology Co., Ltd. (4130)

Kategoria

Historia ceny akcji dla Genovate Biotechnology Co., Ltd. (4130)
Najwyższa cena zamknięcia: $0.87 dnia 2026-07-01

Najniższa cena zamknięcia: $0.15 dnia 2005-06-01
Historia cen akcji firmy Genovate Biotechnology Co., Ltd. od 2005 do 2026
Roczna wydajność ceny akcji
Rok Wydajność
2026 (TTM) 6.42%
2025 24.97%
2024 -22.23%
2023 -16.60%
2022 21.62%
2021 -18.02%
2020 27.33%
2019 -1.89%
2018 -19.60%
2017 -4.24%
2016 -35.79%
2015 -15.23%
2014 65.59%
2013 -5.18%
2012 165.04%
2011 -14.13%
2010 45.34%
2009 70.44%
2008 -33.38%
2007 21.79%
2006 38.76%
2005 0.00%
Cena akcji podobnych firm lub konkurencji
Firma Cena akcji Zmiana 1r% Kraj
$547.71 38.62%
US
$1.04K 58.06%
NL
$145.75 437.43%
US
$118.70 -15.60%
AU
$770.19 8.98%
CH